Skip to main content
Premium Trial:

Request an Annual Quote

Entelos Secures $6.5M Debt Financing

NEW YORK (GenomeWeb News) – Entelos said on Friday that it has signed a debt financing agreement with Imperium Master Fund for a cash loan of $6.5 million.
 
Entelos said it plans to use $1.5 million of the proceeds to repay debt related to its acquisition of Iconix Biosciences in August. The company will use the remaining $5 million as long-term working capital.
 
Imperium will provide Entelos with $1.5 million under a secured bridge note and $5 million under secured convertible debentures.
 
In connection with the bridge note, which will mature in 15 months, Entelos issued to Imperium a five year-term warrant to purchase up to 943,576 shares of common stock at an exercise price per share of $0.4501073 per share.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.